Effects of dexmedetomidine on cesarean section patients: reducing intraoperative shivering and enhancing postoperative analgesia
Phase 4
Recruiting
- Conditions
- cesarean section
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Parturient is more than 37 weeks of single pregnancy; ASAI~II; Elective cesarean section; Aged 20 to 35 years; There was no history of mental illness or drug addiction.
Exclusion Criteria
Refuse intraspinal anesthesia or there are contraindications to intraspinal anesthesia; Refuse to participate in this study; Long-term use of antipsychotics; Having pregnancy complications or the fetus has intrauterine distress and other critical conditions.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does dexmedetomidine target to reduce intraoperative shivering in cesarean section patients?
How does dexmedetomidine compare to standard-of-care antishivering agents in cesarean section anesthesia?
Are there specific biomarkers that predict enhanced postoperative analgesia with dexmedetomidine in cesarean patients?
What adverse events are associated with dexmedetomidine use during cesarean section and how are they managed?
What combination therapies or alternative drugs show similar efficacy to dexmedetomidine for postoperative pain management in cesarean sections?